Mehmet Tarık Tatoğlu

9PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersTumour immunologyAutoimmunityImmunogenetics (incl. genetic immunology)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer.

|Jun 11, 2026
[68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.

|May 21, 2026
Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.

|Feb 09, 2026
Benign thyroid nodule mimicking residual disease on positron emission tomography/computed tomography in a patient with concurrent thyroid and gastric diffuse large B-cell lymphoma: the value of ultrasound-guided biopsy.

Mehmet Tarık Tatoğlu, Mehmet Sait Özsoy

|Jan 19, 2026
A Rare Case of Anti-Yo Positive Paraneoplastic Limbic Encephalitis Associated with Thyroid-Parathyroid Adenoma.

Ezgi Aslan, Asuman Orhan Varoglu, Begumhan Baysal

|Nov 05, 2025
Integrating PET/CT-derived heterogeneity indices and composite risk scores improves prognostic stratification in breast cancer.

Mehmet Tarık Tatoğlu, İlker Nihat Ökten, Ebru İbişoğlu

Pageof 2

Frequent Collaborators

2 joint publications

Ebru İbişoğlu

2 joint publications

Hatice Uslu

2 joint publications

Ferda Yerdelen Tatoğlu

1 joint publications

Ezgi Aslan